Iceland· IS-EU/1/00/170/001-002
Fasturtec
A rasburicase product containing rasburicasum inn, registered in Iceland by Sanofi Winthrop Industrie. The same ATC class is registered in 13 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Rasburicase is registered in 13 of 19 countries.
Countries holding a registration under ATC V03AF07 (rasburicase), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Rasburicase · ATC V03AF07
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Rasburicasum INN
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Iceland (IS)
- ATC code
- V03AF07
- ATC class
- Rasburicase
- Defined daily dose
- 14 mg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean0037751,5 mg x3 hglISK 46076
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for rasburicase.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rasburicase · interactions on record
25 records
- 1 severe
- 24 moderate
Most severe, free to view
- PrilocaineN01BB04severe
- LidocainA01AE01moderate
- TetracainA01AE02moderate
- LidocaineC05AD01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rasburicase in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandFasturtec 1.5 mg / 1 ml, poudre et solvant pour solution à diluer pour perfusionSanofi-Aventis (Suisse) SA
- FinlandFasturtecSanofi Winthrop Industrie
- SpainFASTURTEC 1,5 MG/ML POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONSanofi Winthrop Industrie
- BelgiumFasturtec 1.5 mg/mlSanofi Winthrop Industrie
- SwedenFasturtec 1,5 mg/ml Pulver och vätska till koncentrat till infusionsvätska, lösningSanofi Winthrop Industrie
- IrelandFasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusionSanofi Winthrop Industrie
- NorwayFasturtecSanofi Winthrop Industrie
- PolandFasturtecSanofi Winthrop Industrie
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Fasturtec
- Norway · Fasturtec
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/31a52bd0-82e2-4a5f-aa52-64f20b8b9ca1 GET /v1/drugs/31a52bd0-82e2-4a5f-aa52-64f20b8b9ca1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stofn og leysir fyrir innrennslisþykkni, lausn",
"source": "lyfjastofnun",
"atc_raw": "V03AF07",
"marketed": true,
"strength": "1,5 mg/ml",
"ma_number": "EU/1/00/170/001-002",
"substance": "Rasburicasum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "37027"
}See everything about rasburicase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.